-
1دورية أكاديمية
المؤلفون: Jurisic, Anamarija, Sung, Pei-Ju, Wappett, Mark, Daubriac, Julien, Lobb, Ian T, Kung, Wei-Wei, Crawford, Nyree, Page, Natalie, Cassidy, Eamon, Feutren-Burton, Stephanie, Rountree, J S Shane, Helm, Matthew D, O'Dowd, Colin R, Kennedy, Richard D, Gavory, Gerald, Cranston, Aaron N, Longley, Daniel B, Jacq, Xavier, Harrison, Timothy
المصدر: Jurisic , A , Sung , P-J , Wappett , M , Daubriac , J , Lobb , I T , Kung , W-W , Crawford , N , Page , N , Cassidy , E , Feutren-Burton , S , Rountree , J S S , Helm , M D , O'Dowd , C R , Kennedy , R D , Gavory , G , Cranston , A N , Longley , D B , Jacq , X & Harrison , T 2024 , ' USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by ....
مصطلحات موضوعية: Humans, Vascular Endothelial Growth Factor A, Immune Checkpoint Inhibitors/pharmacology, Ubiquitin-Specific Peptidase 7, Neoplasms, Neovascularization, Pathologic/drug therapy, Fibroblasts/metabolism, Tumor Microenvironment, CCAAT-Enhancer-Binding Proteins/pharmacology, Ubiquitin-Protein Ligases/pharmacology, /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1002/ctm2.1648Test
https://pure.qub.ac.uk/en/publications/5fa479d6-0aa5-4450-8240-97d4b9bc1e29Test
https://pureadmin.qub.ac.uk/ws/files/584466100/Downblast.pdfTest -
2دورية أكاديمية
المؤلفون: El Helali, Aya, Plummer, Ruth, Jayson, Gordon C., Coyle, Vicky M., Drew, Yvette, Mescallado, Nerissa, Harris, Noor, Clamp, Andrew R., McCann, Janine, Swaisland, Helen, Kennedy, Richard D., Cranston, Aaron N., Wilson, Richard H.
وصف الملف: text
العلاقة: http://eprints.gla.ac.uk/271930/1/271930.pdfTest; El Helali, A. et al. (2022) A first-in-human Phase I dose-escalation trial of the novel therapeutic peptide, ALM201, demonstrates a favourable safety profile in unselected patients with ovarian cancer and other advanced solid tumours. British Journal of Cancer , 127(1), pp. 92-101. (doi:10.1038/s41416-022-01780-z ) (PMID:35568736)
-
3دورية أكاديمية
المؤلفون: Obasanmi, Gideon, Nesbit, M. Andrew, Cobice, Diego, Mackay, Logan, McGimpsey, Stuart, Wappett, Mark, Cranston, Aaron N., Moore, Tara C.B.
المساهمون: Almac Discovery Ltd
المصدر: Ophthalmology Science ; volume 2, issue 2, page 100150 ; ISSN 2666-9145
مصطلحات موضوعية: General Medicine
الإتاحة: https://doi.org/10.1016/j.xops.2022.100150Test
https://api.elsevier.com/content/article/PII:S2666914522000392?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2666914522000392?httpAccept=text/plainTest -
4دورية أكاديمية
المؤلفون: Sharma, Ricky A., Plummer, Ruth, Stock, Julie K., Greenhalgh, Tessa A., Ataman, Ozlem, Kelly, Stephen, Clay, Robert, Adams, Richard A., Baird, Richard D., Billingham, Lucinda, Brown, Sarah R., Buckland, Sean, Bulbeck, Helen, Chalmers, Anthony J., Clack, Glen, Cranston, Aaron N., Damstrup, Lars, Ferraldeschi, Roberta, Forster, Martin D., Golec, Julian, Hagan, Russell M., Hall, Emma, Hanauske, Axel-R., Harrington, Kevin J., Haswell, Tom, Hawkins, Maria A., Illidge, Tim, Jones, Hazel, Kennedy, Andrew S., McDonald, Fiona, Melcher, Thorsten, O'Connor, James P. B., Pollard, John R., Saunders, Mark P., Sebag-Montefiore, David, Smitt, Melanie, Staffurth, John, Stratford, Ian J., Wedge, Stephen R.
وصف الملف: text
العلاقة: http://eprints.gla.ac.uk/168118/1/168118.pdfTest; Sharma, R. A. et al. (2018) Clinical development of new drug–radiotherapy combinations. Nature Reviews Clinical Oncology , 13(10), pp. 627-642. (doi:10.1038/nrclinonc.2016.79 ) (PMID:27245279)
-
5دورية أكاديمية
المؤلفون: Sharma, Ricky A., Plummer, Ruth, Stock, Julie K., Greenhalgh, Tessa A., Ataman, Ozlem, Kelly, Stephen, Clay, Robert, Adams, Richard Alexander, Baird, Richard D., Billingham, Lucinda, Brown, Sarah R., Buckland, Sean, Bulbeck, Helen, Chalmers, Anthony J., Clack, Glen, Cranston, Aaron N., Damstrup, Lars, Ferraldeschi, Roberta, Forster, Martin D., Golec, Julian, Hagan, Russell M., Hall, Emma, Hanauske, Axel-R., Harrington, Kevin J., Haswell, Tom, Hawkins, Maria A., Illidge, Tim, Jones, Hazel, Kennedy, Andrew S., McDonald, Fiona, Melcher, Thorsten, O'Connor, James P. B., Pollard, John R., Saunders, Mark P., Sebag-Montefiore, David, Smitt, Melanie, Staffurth, John, Stratford, Ian J., Wedge, Stephen R.
مصطلحات موضوعية: R Medicine (General)
وصف الملف: application/pdf
العلاقة: https://orca.cardiff.ac.uk/id/eprint/94294/1/clinical%20development.pdfTest; Sharma, Ricky A., Plummer, Ruth, Stock, Julie K., Greenhalgh, Tessa A., Ataman, Ozlem, Kelly, Stephen, Clay, Robert, Adams, Richard Alexander https://orca.cardiff.ac.uk/view/cardiffauthors/A104870D.htmlTest orcid:0000-0003-3915-7243 orcid:0000-0003-3915-7243, Baird, Richard D., Billingham, Lucinda, Brown, Sarah R., Buckland, Sean, Bulbeck, Helen, Chalmers, Anthony J., Clack, Glen, Cranston, Aaron N., Damstrup, Lars, Ferraldeschi, Roberta, Forster, Martin D., Golec, Julian, Hagan, Russell M., Hall, Emma, Hanauske, Axel-R., Harrington, Kevin J., Haswell, Tom, Hawkins, Maria A., Illidge, Tim, Jones, Hazel, Kennedy, Andrew S., McDonald, Fiona, Melcher, Thorsten, O'Connor, James P. B., Pollard, John R., Saunders, Mark P., Sebag-Montefiore, David, Smitt, Melanie, Staffurth, John https://orca.cardiff.ac.uk/view/cardiffauthors/A0702394.htmlTest orcid:0000-0002-7834-3172 orcid:0000-0002-7834-3172, Stratford, Ian J. and Wedge, Stephen R. 2016. Clinical development of new drug-radiotherapy combinations. Nature Reviews Clinical Oncology 13 , pp. 627-642. 10.1038/nrclinonc.2016.79 https://doi.org/10.1038/nrclinonc.2016.79Test file https://orca.cardiff.ac.uk/id/eprint/94294/1/clinical%20development.pdfTest
الإتاحة: https://doi.org/10.1038/nrclinonc.2016.79Test
https://orca.cardiff.ac.uk/id/eprint/94294Test/
https://orca.cardiff.ac.uk/id/eprint/94294/1/clinical%20development.pdfTest -
6دورية أكاديمية
المؤلفون: Sharma, Ricky A, Plummer, Ruth, Stock, Julie K, Greenhalgh, Tessa A, Ataman, Ozlem, Kelly, Stephen, Clay, Robert, Adams, Richard A, Baird, Richard D, Billingham, Lucinda, Brown, Sarah R, Buckland, Sean, Bulbeck, Helen, Chalmers, Anthony J, Clack, Glen, Cranston, Aaron N, Damstrup, Lars, Ferraldeschi, Roberta, Forster, Martin D, Golec, Julian, Hagan, Russell M, Hall, Emma, Hanauske, Axel-R, Harrington, Kevin J, Haswell, Tom, Hawkins, Maria A, Illidge, Tim, Jones, Hazel, Kennedy, Andrew S, McDonald, Fiona, Melcher, Thorsten, O'Connor, James PB, Pollard, John R, Saunders, Mark P, Sebag-Montefiore, David, Smitt, Melanie, Staffurth, John, Stratford, Ian J, Wedge, Stephen R, NCRI CTRad Academia-Pharma Joint Working Group
مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols, Cell Hypoxia, Clinical Trials as Topic, Combined Modality Therapy, Drug Approval, Humans, Neoplasms, Patient Education as Topic, Patient Participation, Quality Assurance, Health Care, Quality of Health Care, Radiation Dosage, Radiation Tolerance, Treatment Outcome
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.17863/CAM.469Test
https://www.repository.cam.ac.uk/handle/1810/256522Test -
7دورية أكاديمية
المؤلفون: Swaminathan, Swathi, Cranston, Aaron N., Clyne, Alisa Morss
المصدر: Tissue Engineering Part C: Methods ; volume 25, issue 10, page 609-618 ; ISSN 1937-3384 1937-3392
-
8دورية أكاديمية
المؤلفون: Drosten, Matthias, Hilken, Gero, Böckmann, Miriam, Rödicker, Florian, Mise, Nikica, Cranston, Aaron N., Dahmen, Uta, Ponder, Bruce A. J., Pützer, Brigitte M.
مصطلحات موضوعية: ARTICLES
وصف الملف: text/html
العلاقة: http://jnci.oxfordjournals.org/cgi/content/short/96/16/1231Test; http://dx.doi.org/10.1093/jnci/djh226Test
الإتاحة: https://doi.org/10.1093/jnci/djh226Test
http://jnci.oxfordjournals.org/cgi/content/short/96/16/1231Test -
9
المؤلفون: Sharma, Ricky A, Plummer, Ruth, Stock, Julie K, Greenhalgh, Tessa A, Ataman, Ozlem, Kelly, Stephen, Clay, Robert, Adams, Richard A, Baird, Richard D, Billingham, Lucinda, Brown, Sarah R, Buckland, Sean, Bulbeck, Helen, Chalmers, Anthony J, Clack, Glen, Cranston, Aaron N, Damstrup, Lars, Ferraldeschi, Roberta, Forster, Martin D, Golec, Julian, Hagan, Russell M, Hall, Emma, Hanauske, Axel-R, Harrington, Kevin J, Haswell, Tom, Hawkins, Maria A, Illidge, Tim, Jones, Hazel, Kennedy, Andrew S, McDonald, Fiona, Melcher, Thorsten, O'Connor, James PB, Pollard, John R, Saunders, Mark P, Sebag-Montefiore, David, Smitt, Melanie, Staffurth, John, Stratford, Ian J, Wedge, Stephen R, NCRI CTRad Academia-Pharma Joint Working Group
المساهمون: Baird, Richard [0000-0001-7071-6483], Apollo - University of Cambridge Repository
المصدر: Stratford, I, Sharma, R, Plummer, R, K Stock, J, A Greenhalgh, T, Atamar, O, Kelly, S, Clay, R, Adams, R, D Baird, R, Billingham, L, R Brown, S, Buckland, S, Bulbeck, H, J Chalmers, A, Clack, G, N Cranston, A, Damstrup, L, Ferraldeschi, R, D Forster, M, Golec, J, M Hagan, R, Hall, E, Hanauske, A-R, Harrington, K J, Haswell, T, A Hawkins, M, Illidge, T, Jones, H, S Kennedy, A, S Kennedy, A, McDonald, F, Melcher, T, O'Connor, J, R Pollard, J, Saunders, M P, Sebag-Montefiore, D, Smitt, M, Staffurth, J N & Wedge, S R 2016, ' Clinical Development of new Drug-Radiotherapy Combinations ', Nature Reviews Clinical Oncology, vol. 13, pp. 627-642 . https://doi.org/10.1038/nrclinonc.2016.79Test
مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Quality Assurance, Health Care, medicine.medical_treatment, Radiation Dosage, Radiation Tolerance, Targeted therapy, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, Patient Education as Topic, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Medicine, Combined Modality Therapy, Humans, Medical physics, Proton therapy, Drug Approval, Quality of Health Care, Clinical Trials as Topic, Manchester Cancer Research Centre, business.industry, ResearchInstitutes_Networks_Beacons/mcrc, Cancer, medicine.disease, R1, Cell Hypoxia, Clinical trial, Radiation therapy, 030104 developmental biology, Clinical research, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Patient Participation, business
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5b399e0387a3c3f3edd68863db34342Test
https://eprints.gla.ac.uk/168118/1/168118.pdfTest -
10دورية أكاديمية
المؤلفون: Oplustil O'Connor, Lenka, Rulten, Stuart L, Cranston, Aaron N, Odedra, Rajesh, Brown, Henry, Jaspers, Janneke E, Jones, Louise, Knights, Charlotte, Evers, Bastiaan, Ting, Attilla, Bradbury, Robert H, Pajic, Marina, Rottenberg, Sven, Jonkers, Jos, Rudge, David, Martin, Niall M B, Caldecott, Keith W, Lau, Alan, O'Connor, Mark J
المصدر: Oplustil O'Connor, Lenka; Rulten, Stuart L; Cranston, Aaron N; Odedra, Rajesh; Brown, Henry; Jaspers, Janneke E; Jones, Louise; Knights, Charlotte; Evers, Bastiaan; Ting, Attilla; Bradbury, Robert H; Pajic, Marina; Rottenberg, Sven; Jonkers, Jos; Rudge, David; Martin, Niall M B; Caldecott, Keith W; Lau, Alan; O'Connor, Mark J (2016). The PARP Inhibitor AZD2461 Provides Insights into the Role of PARP3 Inhibition for Both Synthetic Lethality and Tolerability with Chemotherapy in Preclinical Models. Cancer research, 76(20), pp. 6084-6094. American Association for Cancer Research AACR 10.1158/0008-5472.CAN-15-3240
مصطلحات موضوعية: 570 Life sciences, biology, 610 Medicine & health
وصف الملف: application/pdf
العلاقة: https://boris.unibe.ch/96719Test/